ResMed Inc.RMDNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank28
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P28
Within normal range
vs 5Y Ago
-4.7x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -24.89% |
| Q3 2025 | -18.46% |
| Q2 2025 | -8.41% |
| Q1 2025 | 91.50% |
| Q4 2024 | -5.29% |
| Q3 2024 | -26.07% |
| Q2 2024 | 9.20% |
| Q1 2024 | 51.89% |
| Q4 2023 | 1.66% |
| Q3 2023 | 23.51% |
| Q2 2023 | -20.94% |
| Q1 2023 | 159.20% |
| Q4 2022 | 689.06% |
| Q3 2022 | -73.90% |
| Q2 2022 | -27.87% |
| Q1 2022 | -63.77% |
| Q4 2021 | 284.90% |
| Q3 2021 | -149.81% |
| Q2 2021 | 17.06% |
| Q1 2021 | 26.77% |
| Q4 2020 | 5.26% |
| Q3 2020 | -59.47% |
| Q2 2020 | 48.89% |
| Q1 2020 | 393.90% |
| Q4 2019 | -69.46% |
| Q3 2019 | 17.09% |
| Q2 2019 | -4.17% |
| Q1 2019 | 12.52% |
| Q4 2018 | 235.26% |
| Q3 2018 | -70.35% |
| Q2 2018 | -18.16% |
| Q1 2018 | 17.34% |
| Q4 2017 | 50.84% |
| Q3 2017 | -36.74% |
| Q2 2017 | 136.46% |
| Q1 2017 | -50.90% |
| Q4 2016 | 48.93% |
| Q3 2016 | -50.37% |
| Q2 2016 | 30.39% |
| Q1 2016 | -17.99% |